Event Gaps: DeepSeek's picks for 2026-10-06
DeepSeek picked OPCH, APLD, NVAX, STZ, LEVI for a 1-day horizon. Intraday alpha vs SPY: -0.63%. Picks with positive alpha: 60%.
| Experiment | Event Gaps |
|---|---|
| Model | DeepSeek |
| Prompt version | event-gap-v12 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-06 |
| Measured to | 2026-10-07 |
| Benchmark | SPY |
| Status | Settled |
| Intraday alpha vs SPY | -0.63% |
| Picks with positive alpha | 60% |
| Benchmark return | -0.61% |
The picks
| Rank | Symbol | Gap direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | OPCH | -0.06% | -0.06% | 75% | +0.54% | Yes | |
| 2 | APLD | -5.26% | -5.26% | 65% | -4.65% | No | |
| 3 | NVAX | +1.60% | +1.60% | 60% | +2.21% | Yes | |
| 4 | STZ | +0.44% | +0.44% | 55% | +1.05% | Yes | |
| 5 | LEVI | -2.89% | -2.89% | 50% | -2.29% | No |
The model's market view
US equities enter the window with the S&P 500 and Nasdaq at record highs, supported by falling Treasury yields and easing oil prices. Earnings season is just beginning, with a cluster of mid-cap and consumer names reporting. The dominant theme is event-driven dispersion: M&A, earnings surprises, and sentiment-driven short squeezes are creating large single-stock moves even as index-level volatility remains contained. The main risk is that pre-positioning ahead of scheduled catalysts leads to sharp reversals if results or guidance disappoint.
Why each pick
OPCH
Option Care Health agreed to be acquired by McKesson and Clayton Dubilier & Rice for $32.05 per share in cash, a 37% premium to the October 5 close. The stock surged from $23.37 to an intraday high near $31 in pre-market and early trading. The spread between the current price and the $32.05 deal price represents the market's assessment of deal-closing risk, which is modest given the definitive agreement and the strategic nature of the buyer. The main risk is a regulatory block or a financing hiccup, but both are low-probability over a one-day window. The event has already occurred (announcement), and the stock is likely to drift toward the deal price as arbitrageurs establish positions.
APLD
Applied Digital reports fiscal Q1 2027 results after the close on October 7. Options traders are pricing a ±13.55% move, well above the stock's historical average earnings reaction. The company has been volatile, with a 5.77 beta and a recent Finland power deal that added to the AI data center narrative. Revenue is expected to decline sharply as the company transitions from legacy crypto hosting to AI data center leasing, but management has signaled that the decline is mechanical and not a demand problem. The risk is that a messy headline number triggers a sell-off before investors digest the underlying growth story. Anticipation ahead of the report could keep the stock elevated into the event.
NVAX
Novavax surged 20% on October 5 amid unconfirmed reports of pneumonic plague cases in Siberia, triggering a short squeeze with 30.43% of the float sold short. The rally is sentiment-driven rather than fundamental, as Novavax has no direct link to plague vaccines. The high short interest and elevated volume create the potential for a continuation squeeze if the news cycle persists, but the move is highly vulnerable to a reversal if the reports are debunked or if no further headlines emerge. The event is uncertain and ongoing, with no scheduled resolution.
STZ
Constellation Brands reports fiscal Q2 2027 results after the close on October 6, with a conference call on October 7. Options imply a ±5.3% move. The stock is near a 52-week low and has fallen sharply on fears of weakening beer volumes, particularly among Hispanic consumers. The valuation is the cheapest in over a decade, and a beat on depletions or a reaffirmed full-year guidance could trigger a relief rally. The risk is that cautious management commentary on volumes or further tariff headwinds drives the stock lower. The event is scheduled and will occur within the window.
LEVI
Levi Strauss reports fiscal Q3 2026 results after the close on October 7, with options implying a move of roughly 8–15%. The stock has been range-bound around $20 and is up 2% in the days before the report. The key risks are consumer discretionary spending weakness and margin pressure from tariffs. A beat on revenue or gross margin, or improved full-year guidance, could push the stock higher. A miss or cautious guidance could send it back to the lower end of the range. The event is scheduled for after the window closes, so anticipation and positioning will drive the stock during the window.
Other models on the same run
| Model | Picks | Intraday alpha vs SPY | Picks with positive alpha |
|---|---|---|---|
| GPT-5.6 Sol | MRVL, CEG, LW, ZS, CLF | -0.81% | 40% |
| Perplexity | PENG, STZ, APLD, LW, LEVI | +3.00% | 40% |
| Muse Spark 1.1 | LW, STZ, APLD, LEVI, PEP | -1.25% | 40% |
| Claude Sonnet 5.5 | LW, MRVL, PENG, STZ, NEOG | +5.46% | 80% |
| Gemini 1.5 Pro | OPCH, LW, STZ, PTC, APLD | -0.30% | 80% |
| Grok 4.5 | PENG, APLD, STZ, LEVI, NEOG | +2.14% | 40% |
Written up on ForecastNest Insights: Event Gaps: DeepSeek's picks for 2026-10-06.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.